Related references
Note: Only part of the references are listed.Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of Life
Kenneth Maswabi et al.
CLINICAL INFECTIOUS DISEASES (2021)
Early antiretroviral therapy-treated perinatally HIV-infected seronegative children demonstrate distinct long-term persistence of HIV-specific T-cell and B-cell memory
Nicola Cotugno et al.
AIDS (2020)
Time to Viral Suppression in Perinatally HIV-Infected Infants Depends on the Viral Load and CD4 T-Cell Percentage at the Start of Treatment
Juliane Schroter et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2020)
Impact of Early Antiretroviral Therapy Initiation on HIV-Specific CD4 and CD8 T Cell Function in Perinatally Infected Children
Stefano Rinaldi et al.
JOURNAL OF IMMUNOLOGY (2020)
Quantifying the Dynamics of HIV Decline in Perinatally Infected Neonates on Antiretroviral Therapy
Sinead E. Morris et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2020)
HIGH-FREQUENCY failure of combination antiretroviral therapy in paediatric HIV infection is associated with unmet maternal needs causing maternal NON-ADHERENCE
Jane R. Millar et al.
ECLINICALMEDICINE (2020)
Early antiretroviral treatment of infants to attain HIV remission
Louise Kuhn et al.
ECLINICALMEDICINE (2020)
Reduced Time to Suppression Among Neonates With HIV Initiating Antiretroviral Therapy Within 7 Days After Birth
Sara Dominguez-Rodriguez et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2019)
Early and Highly Suppressive Antiretroviral Therapy Are Main Factors Associated With Low Viral Reservoir in European Perinatally HIV-Infected Children
Alfredo Tagarro et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2018)
Early antiretroviral therapy in HIV-infected infants: can it lead to HIV remission?
Stephanie Shiau et al.
LANCET HIV (2018)
Early age at start of antiretroviral therapy associated with better virologic control after initial suppression in HIV-infected infants
Stephanie Shiau et al.
AIDS (2017)
Viremic Relapse after HIV-1 Remission in a Perinatally Infected Child
Katherine Luzuriaga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Early Antiretroviral Therapy in South African Children Reduces HIV-1-Infected Cells and Cell-Associated HIV-1 RNA in Blood Mononuclear Cells
Gert U. van Zyl et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Group-Based Trajectory Modeling: An Overview
Daniel S. Nagin
ANNALS OF NUTRITION AND METABOLISM (2014)
Immunology of pediatric HIV infection
Nicole H. Tobin et al.
IMMUNOLOGICAL REVIEWS (2013)
Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant
Deborah Persaud et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Mortality and Long-term Virologic Outcomes in Children and Infants Treated With Lopinavir/Ritonavir
Dora Estripeaut et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Sex Differences in HIV RNA Level and CD4 Cell Percentage During Childhood
Theodore D. Ruel et al.
CLINICAL INFECTIOUS DISEASES (2011)
Group-Based Trajectory Modeling in Clinical Research
Daniel S. Nagin et al.
ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 6 (2010)
Methodological issues in the use of composite endpoints in clinical trials: examples from the HIV field
Linda Wittkop et al.
CLINICAL TRIALS (2010)
Five-year follow-up of children with perinatal HIV-1 infection receiving early highly active antiretroviral therapy
Elena Chiappini et al.
BMC INFECTIOUS DISEASES (2009)
Pediatric HIV-1 in Kenya: Pattern and Correlates of Viral Load and Association With Mortality
Elizabeth Maleche Obimbo et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Gender differences in lymphocyte populations, plasma HIV RNA levels, and disease progression in a cohort of children born to women infected with HIV
Marc Foca et al.
PEDIATRICS (2006)
Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis
JPA Ioannidis et al.
AIDS (2004)
Maternal health factors and early pediatric antiretroviral therapy influence the rate of perinatal HIV-1 disease progression in children
EJ Abrams et al.
AIDS (2003)
Virologic and regimen termination surrogate end points in AIDS clinical trials
PB Gilbert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
A SAS procedure based on mixture models for estimating developmental trajectories
BL Jones et al.
SOCIOLOGICAL METHODS & RESEARCH (2001)
Considerations in choosing a primary endpoint that measures durability of virological suppression in an antiretroviral trial
PB Gilbert et al.
AIDS (2000)
Share Paper
